Callan Jmb Inc (CJMB)

NASD · Industrials · Integrated Freight & Logistics · USA

Callan Jmb Inc is a micro cap company (market value under $300 million) in the Integrated Freight & Logistics industry.

Callan JMB provides thermal management logistics and fulfillment solutions to the life sciences industry through proprietary packaging and specialized cold chain expertise. The company serves customers requiring temperature-controlled shipping for biologics, vaccines, cell therapies, and other sensitive materials, offering emergency response, specialty packaging, and advanced monitoring technology.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Callan Jmb Inc stock.

Our verdict on CJMB

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.

ETFs with the most weight in CJMB

Browse

Peers in Integrated Freight & Logistics

All 32 Integrated Freight & Logistics stocks

Cheaper than CJMB in Integrated Freight & Logistics

10 more in this industry show a wider margin of safety.

Is CJMB undervalued or overvalued?

We do not publish a verdict on CJMB yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of CJMB?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.